• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reponse to: comment on, 'Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'.

作者信息

Downey C L, Simpkins S A, Holliday D L, Jones J L, Jordan L B, Kulka J, Hanby A M, Speirs V

机构信息

Leeds Institute of Cancer & Pathology, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK.

Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.

出版信息

Br J Cancer. 2015 May 26;112(11):1833-4. doi: 10.1038/bjc.2014.571. Epub 2014 Nov 13.

DOI:10.1038/bjc.2014.571
PMID:25393369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4647241/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2856/4647241/97e5d130e5f1/bjc2014571f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2856/4647241/97e5d130e5f1/bjc2014571f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2856/4647241/97e5d130e5f1/bjc2014571f1.jpg

相似文献

1
Reponse to: comment on, 'Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'.对《雌激素受体阳性乳腺癌患者的肿瘤-基质比率（TSR）》评论的回复
Br J Cancer. 2015 May 26;112(11):1833-4. doi: 10.1038/bjc.2014.571. Epub 2014 Nov 13.
2
Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer.关于《雌激素受体阳性乳腺癌中肿瘤-基质比值的预后意义》的评论
Br J Cancer. 2015 May 26;112(11):1832-3. doi: 10.1038/bjc.2014.570. Epub 2014 Nov 13.
3
The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer.肿瘤-基质比在雌激素受体阳性乳腺癌中的预后意义。
Br J Cancer. 2014 Apr 2;110(7):1744-7. doi: 10.1038/bjc.2014.69. Epub 2014 Feb 18.
4
PET imaging of oestrogen receptors in patients with breast cancer.乳腺癌患者雌激素受体的 PET 成像。
Lancet Oncol. 2013 Oct;14(11):e465-e475. doi: 10.1016/S1470-2045(13)70292-4.
5
The prognostic value of tumour-stroma ratio in triple-negative breast cancer.肿瘤间质比在三阴性乳腺癌中的预后价值。
Eur J Surg Oncol. 2012 Apr;38(4):307-13. doi: 10.1016/j.ejso.2012.01.002. Epub 2012 Jan 20.
6
Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.一大群雌激素受体阳性乳腺癌患者中肿瘤特征、SUV测量值、代谢肿瘤体积、总病变糖酵解与通过F-FDG PET评估的纹理特征之间的相关性
Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1145-1154. doi: 10.1007/s00259-017-3641-4. Epub 2017 Feb 10.
7
First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.支持骨形态发生蛋白/信号转导分子 Mothers Against Decapentaplegic（BMP/SMAD）信号通路在雌激素受体阳性乳腺癌进展中可能发挥作用的首个证据。
J Pathol. 2005 Jul;206(3):366-76. doi: 10.1002/path.1785.
8
Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.淋巴结阴性、雌激素受体阳性乳腺癌的治疗：国家外科辅助乳腺和肠道项目随机临床试验的长期结果
Lancet. 2004;364(9437):858-68. doi: 10.1016/S0140-6736(04)16981-X.
9
Frequency of distribution of oestrogen and progesterone receptors positivities in breast cancer cases in Benin-City, Nigeria.尼日利亚贝宁城乳腺癌病例中雌激素和孕激素受体阳性的分布频率。
Niger Postgrad Med J. 2012 Mar;19(1):19-24.
10
Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing.人表皮生长因子受体 2（HER2）阳性乳腺癌的特征，这些乳腺癌是在普遍开展 HER2 检测之后诊断出来的。
Breast. 2012 Dec;21(6):724-9. doi: 10.1016/j.breast.2012.09.001. Epub 2012 Oct 23.

引用本文的文献

1
The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer.肿瘤内基质含量在小叶型乳腺癌中的预后作用
Cancers (Basel). 2022 Feb 14;14(4):941. doi: 10.3390/cancers14040941.
2
The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review.肿瘤-基质比在原发性乳腺癌中的预后价值，特别关注三阴性肿瘤：综述。
Breast Cancer Res Treat. 2019 Jan;173(1):55-64. doi: 10.1007/s10549-018-4987-4. Epub 2018 Oct 9.

本文引用的文献

1
The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer.可手术切除的导管型乳腺癌患者的肿瘤间质百分比、临床病理特征与预后之间的关系。
Br J Cancer. 2014 Jul 8;111(1):157-65. doi: 10.1038/bjc.2014.279. Epub 2014 May 29.
2
The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer.肿瘤-基质比在雌激素受体阳性乳腺癌中的预后意义。
Br J Cancer. 2014 Apr 2;110(7):1744-7. doi: 10.1038/bjc.2014.69. Epub 2014 Feb 18.
3
Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854).
肿瘤间质比的预后意义：来自 EORTC 围手术期化疗（POP）试验（10854）的淋巴结阴性绝经前乳腺癌患者的验证研究。
Breast Cancer Res Treat. 2013 Jun;139(2):371-9. doi: 10.1007/s10549-013-2571-5. Epub 2013 May 25.
4
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.肿瘤间质比例作为 II 期和 III 期结肠癌患者的强预后因素：VICTOR 试验的验证。
Ann Oncol. 2013 Jan;24(1):179-85. doi: 10.1093/annonc/mds246. Epub 2012 Aug 2.
5
Accessories to the crime: functions of cells recruited to the tumor microenvironment.肿瘤微环境中募集的细胞的功能：犯罪的帮凶。
Cancer Cell. 2012 Mar 20;21(3):309-22. doi: 10.1016/j.ccr.2012.02.022.
6
Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsies.食管腺癌活检中肿瘤间质比评分的可重复性和验证。
Eur J Cancer. 2011 Feb;47(3):375-82. doi: 10.1016/j.ejca.2010.09.043. Epub 2010 Oct 29.
7
Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients.原发肿瘤的肿瘤间质比是早期乳腺癌患者的预后因素，尤其是三阴性乳腺癌患者。
Breast Cancer Res Treat. 2011 Feb;125(3):687-96. doi: 10.1007/s10549-010-0855-6. Epub 2010 Apr 2.
8
The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy?食管腺癌的基质部分：它是否隐藏了治疗靶点？
Eur J Cancer. 2010 Mar;46(4):720-8. doi: 10.1016/j.ejca.2009.12.006. Epub 2010 Jan 13.
9
Tubular carcinoma of the breast: further evidence to support its excellent prognosis.乳腺管状癌：进一步支持其良好预后的证据。
J Clin Oncol. 2010 Jan 1;28(1):99-104. doi: 10.1200/JCO.2009.23.5051. Epub 2009 Nov 16.
10
Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients.大量基质的存在以及SMAD4的下调预示着I-II期结肠癌患者的生存预后更差。
Cell Oncol. 2009;31(3):169-78. doi: 10.3233/CLO-2009-0478.